Header menu link for other important links
X
Quantitative structure-activity relationships for commercially available inhibitors of COX-2
Ponnurengan Malliappan Sivakumar,
Published in
2008
PMID: 18336329
Volume: 4
   
Issue: 2
Pages: 110 - 115
Abstract
Quantitative structure activity relationship (QSAR) studies of selective COX-2 inhibitors of commercial interest (drugs in market and on clinical trials) were performed. The COX-2 inhibitory activity (pIC50=-logIC50) of these twelve compounds was correlated with nineteen descriptors including steric, electronic and constitutional parameters. pIC50 activity showed high positive correlation with both volume and HOMO (Highest occupied molecular orbital). A Bi-parametric model was developed that included both these descriptors. The predictive capability (q2=0.66) of this equation was satisfactory. So it can be used to design newer templates or modify existing templates. Volume is an important parameter for the selective COX-2 inhibitory activity, because the secondary pocket in the active site of this enzyme is bigger than the active site of COX-1 enzyme (by 17%). HOMO is a measure of the nucleophilicity of the molecule and a molecule with high HOMO energy is ready to donate its electrons and thus is more reactive than molecule with low values. Binding studies were performed between the COX-2 enzyme and these molecules. The inhibitory activity increased with decrease in binding energy (or interaction energy) between the compounds with the COX-2 enzyme (with a correlation coefficient = -0.65). Calculated Log BBB (Blood Brain barrier), Log P (octonol water partition), and HBD (hydrogen bond donor) values were in the acceptable range (i.e., BBB = -1 to 0.3; LogP= 0 to 5; HBD < 5). © 2008 Bentham Science Publishers Ltd.
About the journal
JournalMedicinal Chemistry
ISSN15734064
Open AccessNo
Concepts (47)
  •  related image
    1 (4 FLUOROPHENYL) 2 [(4 METHYLSULFONYL)PHENYL]CYCLOPENTENE
  •  related image
    4 [5 (4 BROMOPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE
  •  related image
    5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE
  •  related image
    5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE
  •  related image
    Celecoxib
  •  related image
    CYCLOOXYGENASE 2
  •  related image
    CYCLOOXYGENASE 2 INHIBITOR
  •  related image
    L 768 277
  •  related image
    N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE
  •  related image
    NIMESULIDE
  •  related image
    PROSTAGLANDIN SYNTHASE INHIBITOR
  •  related image
    ROFECOXIB
  •  related image
    SC 58451
  •  related image
    VALDECOXIB
  •  related image
    CYCLOOXYGENASE 2
  •  related image
    CYCLOOXYGENASE 2 INHIBITOR
  •  related image
    Article
  •  related image
    Binding affinity
  •  related image
    Binding site
  •  related image
    Blood brain barrier
  •  related image
    Computer model
  •  related image
    Computer prediction
  •  related image
    Drug penetration
  •  related image
    Drug protein binding
  •  related image
    Drug structure
  •  related image
    Enzyme activity
  •  related image
    IC 50
  •  related image
    Mathematical computing
  •  related image
    Priority journal
  •  related image
    Quantitative analysis
  •  related image
    Structure activity relation
  •  related image
    Chemical structure
  •  related image
    Chemistry
  •  related image
    Human
  •  related image
    Hydrogen bond
  •  related image
    Protein binding
  •  related image
    Quantitative structure activity relation
  •  related image
    Solubility
  •  related image
    Binding sites
  •  related image
    Blood-brain barrier
  •  related image
    CYCLOOXYGENASE 2
  •  related image
    CYCLOOXYGENASE 2 INHIBITORS
  •  related image
    Humans
  •  related image
    Hydrogen bonding
  •  related image
    Inhibitory concentration 50
  •  related image
    Models, molecular
  •  related image
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP